A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
Status:
Terminated
Trial end date:
2017-05-22
Target enrollment:
Participant gender:
Summary
This is a study to determine the clinical benefit (how well the drug works), safety and
tolerability of combining varlilumab and atezolizumab. Phase l of the study will enroll
patients with a number of tumor types; Phase ll will enroll only patients with renal cell
carcinoma (RCC).*
*Note: This Study was terminated prior to initiation of Phase II